Cite
HARVARD Citation
Zeuzem, S. et al. (2013). Faldaprevir (Bi 201335), Deleobuvir (Bi 207127) and Ribavirin Oral Therapy for Treatment-Naive HCV Genotype 1: Sound-C1 Final Results. Antiviral therapy. 18 (8), pp. 1015-1019. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zeuzem, S. et al. (2013). Faldaprevir (Bi 201335), Deleobuvir (Bi 207127) and Ribavirin Oral Therapy for Treatment-Naive HCV Genotype 1: Sound-C1 Final Results. Antiviral therapy. 18 (8), pp. 1015-1019. [Online].